💓 Blood Pressure · 11 min read · Subtopic 4 of 5

The Adherence Math

Blood pressure medication has two half-lives, and confusing them causes most of the trouble. One is the drug's — the hours it lingers in your body after a missed dose. The other is persistence — the months before half of all prescriptions quietly end. This page separates the two, works the arithmetic of once-daily dosing, and gives you the honest missed-dose rules. It is education about how adherence behaves, not instruction in dosing: what to do after a missed dose is a pharmacist-and-prescriber conversation, with one rule that never varies.

🔎 Evidence Snapshot ★★★☆☆ Moderate — the persistence numbers are solid and sobering; which adherence fix works for which person is far less settled

What the evidence supports

  • About half of people starting a blood pressure medication have stopped within a year — the persistence half-life, measured electronically in the Vrijens study.
  • Adherence falls as dosing frequency rises: once-daily regimens consistently beat twice- and three-times-daily ones in meta-analyses.
  • Morning versus evening timing makes little difference to outcomes — the TIME trial found no material difference — so the schedule you remember wins.

What remains uncertain

  • Why one person forgets and another does not is only partly understood; cost, side effects, and routine each contribute differently by person.
  • Which adherence intervention — pillboxes, apps, pharmacist check-ins, single-pill forms — works best in whom has mixed evidence.
  • How quickly and completely control slips after a missed dose varies with the drug's half-life and the person's baseline; the general rules are safer than the specific predictions.

Evidence last reviewed: August 20, 2026. Conclusions may change as new research is published.

the handoff conversation

The Two Half-Lives

The word "half-life" gets used for two very different numbers, and keeping them apart changes how you read everything that follows. The drug half-life is pharmacology: how long it takes your body to clear half of a dose. For amlodipine that is long — a day and a half or more — which is why a missed dose barely registers. For many ACE inhibitors and ARBs it is shorter — a matter of hours — which is why a skipped evening shows up in the next day's reading. The persistence half-life is behavior: how long before half of the people who started a prescription are no longer taking it. That number is about a year, and it has nothing to do with chemistry.

The Side-Effect Conversation and Two-Drug Reality pages explain the two biggest reasons persistence fails — symptoms never reported, and regimens too complicated to survive real life. This page adds the arithmetic: what a missed dose actually costs, and why the once-daily form is the strongest single design choice in the whole treatment.

The Missed-Dose Math

The drug half-life sets the shape of the problem. The table below is a rough pharmacokinetic map — bands, not precise numbers, because half-lives vary with age, kidneys, and the specific drug in the class.

ClassTypical half-life bandWhat one missed dose tends to doReading
🟢 Long-acting CCBs (amlodipine)Roughly 30–50 hoursLittle — the drug lingers; two missed days start to matterForgiving
🟡 ACE inhibitors / ARBsRoughly 6–12 hoursThe next day's reading may run higher; control wobblesBrittle
🟡 Thiazide diureticsRoughly 6–15 hoursSimilar — a skip shows as a higher reading within a day or twoBrittle
🔴 Beta-blockers (if prescribed)Variable, often shortFast heart rate or chest discomfort can appear if stopped abruptlyNever stop abruptly

The universal rule that never varies: if a dose is missed, do not double up on the next one. Resume the normal schedule and tell the prescriber or pharmacist what happened. For the specifics — whether to take a forgotten pill tonight depends on the drug and the hours — a pharmacist is the right person to ask, and the Question List page carries the exact wording for the next visit.

The Dose-Frequency Curve

Here is the arithmetic the once-daily argument is built on. A classic meta-analysis of antihypertensive studies measured adherence against how many times a day the regimen demanded action:

Adherence by Dosing Frequency
Approximate adherence rates from a meta-analysis of antihypertensive pharmacotherapy — fewer daily acts, more doses taken
Once daily ~79% Twice daily ~69% Three times daily ~65% Four times daily ~51% approximately meta-analytic rates — the slope is the message: complexity is a dose in itself

The slope between the first bar and the last is the whole once-daily argument: each additional daily act costs roughly ten percentage points of adherence. That is why guidelines favor once-daily agents that cover the full 24 hours, why combination pills exist — one act, two classes — and why the parent topic Medications & the Handoff treats "morning or evening?" as a real question rather than a formality.

Morning, Evening, or Just Remembered

The timing question got a definitive answer in 2022, when the TIME trial followed more than 21,000 people randomized to take their usual blood pressure medications in the morning or the evening. Cardiovascular outcomes were essentially identical between the groups — evening dosing does not confer a magic nighttime advantage, and morning dosing does not carry a penalty. What did differ was adherence: the morning group was modestly more likely to stay consistent, because a morning dose can be anchored to a standing habit — coffee, breakfast, toothbrush — while an evening dose competes with the day's end.

The practical conclusion is gentle: the schedule that survives your actual life is the right schedule, and it is a conversation with your prescriber, not a fixed doctrine. What the science protects against is the false belief that there is one perfect hour — the perfect hour is the one that gets taken.

Why People Stop — the Honest List

The persistence half-life has causes, and they are mostly not the ones people confess at visits.

⚠️ The missed-dose rules that never vary

Never double a dose to catch up. Never stop, halve, or skip doses to "test" whether you still need them — abrupt stops carry real rebound risk with some classes. Resume at the normal schedule, note it in the log, and tell the prescriber. The safe experiment of reducing or stopping is a supervised one, and only the person who prescribed can run it.

Measuring Your Own Adherence Honestly

Adherence is measurable, and the measurement is embarrassing-free if you frame it as data. Three quick checks give you most of the truth.

~50%
of people starting a blood pressure medication have stopped within a year — the persistence cliff
79% vs 51%
adherence once daily versus four times daily in the meta-analysis — each daily act costs about ten points
24h
the coverage goal behind the once-daily argument — one act should span the full day

Questions, Answered Briefly

The Bottom Line

  1. Two half-lives, one page. The drug's half-life is hours; persistence is about a year. Confusing them is how people think one missed dose is fine forever, or that a year of silence is a medical event.
  2. Complexity is a dose in itself. Each additional daily act costs roughly ten percentage points of adherence — the arithmetic behind once-daily drugs and single-pill combinations.
  3. Timing is personal, not mystical. The TIME trial cleared morning versus evening; the schedule that survives your life is the one that works.
  4. The missed-dose rules never vary: resume at the normal dose, never double up, never stop abruptly, and let the supervised experiment stay supervised.

Related Topics

Sources & further reading